Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 
Open AccessResearch

A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages

Kevin R Mott1 email, David UnderHill2 email, Steven L Wechsler3,4,5 email, Terrence Town6,7 email and Homayon Ghiasi1 email

Center for Neurobiology & Vaccine Development, Ophthalmology Research, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

The Gavin Herbert Eye Institute, University of California, Irvine, CA, USA

The Department of Microbiology and Molecular Genetics, University of California, Irvine, School of Medicine, Irvine, CA, USA

Center for Virus Research, University of California, Irvine, USA

Departments of Neurosurgery and Biomedical Sciences, Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

author email corresponding author email

Virology Journal 2009, 6:56doi:10.1186/1743-422X-6-56

Published: 13 May 2009

Abstract

Background

Macrophages and dendritic cells (DCs) play key roles in host defense against HSV-1 infection. Although macrophages and DCs can be infected by herpes simplex virus type 1 (HSV-1), both cell types are resistant to HSV-1 replication. The aim of our study was to determine factor (s) that are involved in the resistance of DCs and macrophages to productive HSV-1 infection.

Results

We report here that, in contrast to bone marrow-derived DCs and macrophages from wild type mice, DCs and macrophages isolated from signal transducers and activators of transcription-1 deficient (STAT1-/-) mice were susceptible to HSV-1 replication and the production of viral mRNAs and DNA. There were differences in expression of immediate early, early, and late gene transcripts between STAT1+/+ and STAT1-/- infected APCs.

Conclusion

These results suggest for the first time that the JAK-STAT1 pathway is involved in blocking replication of HSV-1 in DCs and macrophages.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.